Concepedia

Karel Geboes

KG

Statistics

Publications

141

Citations

12.4K

H-Index

59

Active since

1980

Affiliations

KU Leuven(Current)

King Saud University

Universitair Ziekenhuis Leuven

Rega Institute for Medical Research

King Abdulaziz University

Karel Geboes is an author at KU Leuven specializing in medicine, inflammatory bowel disease, and inflammation.

Publications per year

1980–2019

141

Publications

141

Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial

Paul Rutgeerts, Gert Van Assche, William J. Sandborn et al. · Gastroenterology · 2012 · 581 citations

Life Sciences, Immunology, Pharmacotherapy +16

Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis

Filip J. Baert, Geert D’Haens, Marc Peeters et al. · Gastroenterology · 1999 · 467 citations · Full text

Life Sciences, Immunology, Pathology +12

Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trial

Paul Rutgeerts, Gert Van Assche, Séverine Vermeire et al. · Gastroenterology · 2005 · 420 citations · Full text

Pharmacy, Pharmacotherapy, Surgery +13

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

Ingrid Arijs, K. Li, Gary Toedter et al. · Gut · 2009 · 409 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease

Peter Suenaert, Veerle Bulteel, Liesbeth Lemmens et al. · The American Journal of Gastroenterology · 2002 · 389 citations

Life Sciences, Immunology, Immunoregulation +13

1–5 of 141